China Acne Therapeutics Market Analysis Report 2022 to 2030

China Acne Therapeutics Market Analysis

$ 3999

China's acne therapeutics market is expected to witness growth from $806 Mn in 2022 to $1,515 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-30. The main market drivers of this market are growing sedentary lifestyles and demand for minimally invasive cosmetic treatment in China. The market is segmented by treatment, route of administration, age group, and distribution channel. Botanix Pharmaceuticals, Galderma, and Bausch are some of the key players in the China acne therapeutics market.

ID: IN10CNPH027 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Parul Choudhary

Buy Now

China Acne Therapeutics Market Executive Analysis

China's acne therapeutics market is expected to witness growth from $806 Mn in 2022 to $1,515 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-30. In December 2022, $46.05 Bn in data related to health and family planning was recorded. This represents an increase from the prior figure of $28.02 Bn for November 2022. The information peaked at $46.05 Bn in December 2022 and hit a record low of $0.86 Bn in January 2007. China's health spending as a percentage of GDP in 2022 was 5.4%. From 4.5% of GDP in 2000 to 5.4% of GDP in 2022, China's health spending as a percentage of GDP climbed at an average yearly rate of 1.00%.

Acne vulgaris has a significant patient population in China because of the country's large population base, which has resulted in a very substantial illness burden for both patients and society. According to a number of studies, the prevalence of acne is thought to range between 8.1 to 85.1% in China. Effective therapies can considerably enhance the quality of life, skin appearance, and self-esteem. However, poor patient compliance with acne treatments certainly reduces their therapeutic impact. ASC40's phase II clinical trial for the treatment of acne patients has received approval from China National Medical Products Administration (NMPA). Patients with moderate to severe acne will participate in a phase II trial to assess the safety and effectiveness of ASC40.

china acne therapeutics market analysis

Market Dynamics

Market Growth Drivers

Growing sedentary lifestyles, poor eating habits, and the demand for less invasive cosmetic treatment methods have all contributed to rising rates of acne vulgaris in adults and teens as well as increased China's acne therapeutics market growth.

Market Restraints

China's acne therapeutics market expansion is being hampered by concerns about the safety of the drugs used to treat acne.

Competitive Landscape

Key Players

Sinopharm (CHN)
Shanghai Pharmaceuticals (CHN)
Jiangsu Hengrui Medicine (CHN)
China Meheco (CHN)
Botanix Pharmaceuticals
Galderma
Bausch
GlaxoSmithKline
Bayer
Valeant Pharmaceutical

Healthcare Policies and Regulatory Landscape

Urban Employee Basic Medical Insurance in China receives little government financing and is mostly supported by employee and employer payroll taxes. In urban regions of China, participation is mandatory for all employees. Rural residents are also covered by the Urban-Rural Resident Basic Medical Insurance, along with self-employed people, children, elderly people, and others. Insurance is optional for households. Local governments determine each benefit package, which often includes hospital inpatient treatment, general and specialty care, prescription medications, etc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Acne Therapeutics Market Segmentation

By Treatment (Revenue, USD Billion):

Therapeutics
- Retinoid
- Antibiotics
- Hormonal Agents
- Anti-Inflammatory
- Other Agents
- Other Treatments

By Route of Administration (Revenue, USD Billion):

Oral
Topical
Injectable

By Age Group (Revenue, USD Billion):

10 to 17
18 to 44
45 to 64
65 and above

By Distribution Channel (Revenue, USD Billion):

Hospital Pharmacies
Retail and Online Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.